Strata Skin Sciences, Inc. (SSKN) Issues Quarterly Earnings Results, Beats Estimates By $0.19 EPS
Strata Skin Sciences, Inc. (NASDAQ:SSKN) announced its earnings results on Thursday. The medical device company reported ($0.52) earnings per share for the quarter, beating the consensus estimate of ($0.71) by $0.19, Morningstar.com reports. Strata Skin Sciences had a negative net margin of 13.13% and a negative return on equity of 26.42%. The firm had revenue of $8.70 million during the quarter, compared to the consensus estimate of $7.98 million.
Shares of Strata Skin Sciences (NASDAQ SSKN) traded down 8.21% on Friday, reaching $1.79. 16,804 shares of the company traded hands. The company’s market capitalization is $4.34 million. Strata Skin Sciences has a 52-week low of $0.43 and a 52-week high of $5.40. The firm has a 50-day moving average of $2.09 and a 200-day moving average of $1.79.
SSKN has been the subject of several analyst reports. Rodman & Renshaw boosted their target price on shares of Strata Skin Sciences from $1.50 to $12.00 and gave the company a “buy” rating in a research note on Tuesday, May 16th. ValuEngine raised shares of Strata Skin Sciences from a “strong sell” rating to a “sell” rating in a research note on Friday, June 16th. Finally, HC Wainwright set a $12.00 target price on shares of Strata Skin Sciences and gave the company a “buy” rating in a research note on Friday.
About Strata Skin Sciences
STRATA Skin Sciences, Inc, formerly MELA Sciences, Inc, is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging.
Receive News & Ratings for Strata Skin Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.